Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Quality medicines for the poor

Experience of the Delhi programme on rational use of drugs

Dados Bibliográficos

ID11490702
AutoresRanjit Roy Chaudhury (National Institute of Immunology, autor correspondente), R Parameswar, Umesh Gupta (0000-0001-7717-1404), Sangeeta Sharma (0000-0002-2179-8264), Uma Tekur, JS Bapna
Ano2005
Volume20
Fascículo2
Páginas124-136
Data de publicação2005-03-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoHealth Policy and Planning (JOURNAL)
Identificadores do periódicoISSN: 0268-1080 • E-ISSN: 1460-2237
EditoraOxford University Press (PUBLISHER • GB)
DOI10.1093/heapol/czi015
PMID15746221
OpenAlexW1975605663
IdiomaEN
Citações recebidas11
Referências citadas1

Prior to 1994, most Delhi hospitals and dispensaries experienced constant shortages of essential medicines. There was erratic prescribing of expensive branded products, frequent complaints about poor drug quality and low patient satisfaction. Delhi took the lead in developing a comprehensive Drug Policy in 1994 and was the only Indian state to have such a comprehensive policy. The policy's main objective is to improve the availability and accessibility of quality essential drugs for all those in need. The Delhi Society for the Promotion of Rational Use of Drugs (DSPRUD), a non-governmental organization, worked in close collaboration with the Delhi Government and with universities to implement various components of the policy. The first Essential Drugs List (EDL) was developed, a centralized pooled procurement system was set up and activities promoting rational use of drugs were initiated. In 1997, the Delhi Programme was designated the INDIA-WHO Essential Drugs Programme by the World Health Organization. The EDL was developed by a committee consisting of a multidisciplinary group of experts using balanced criteria of efficacy, safety, suitability and cost. The first list contained 250 drugs for hospitals and 100 drugs for dispensaries; the list is revised every 2 years. The pooled procurement system, including the rigorous selection of suppliers with a minimum annual threshold turnover and the introduction of Good Manufacturing Practice inspections, resulted in the supply of good quality drugs and in holding down the procurement costs of many drugs. Bulk purchasing of carefully selected essential drugs was estimated to save nearly 30% of the annual drugs bill for the Government of Delhi, savings which were mobilized for procuring more drugs, which in turn improved availability of drugs (more than 80%) at health facilities. Further, training programmes for prescribers led to a positive change in prescribing behaviour, with more than 80% of prescriptions being from the EDL and patients receiving 70-95% of the drugs prescribed. These changes were achieved by changing managerial systems with minimal additional expenditure. The 'Delhi Model' has clearly demonstrated that such a programme can be introduced and implemented and can lead to a better use and availability of medicines.

Business · Developing country · Economic growth · Economic shortage · Economics · Environmental health · Essential drugs · Essential medicines · Government (linguistics) · Health care · Political science · Population · Procurement · Promotion (chess) · Purchasing · Quality (philosophy) · Healthcare Systems and Reforms · Marketing · Medicine · Pharmaceutical Economics and Policy · Pharmaceutical Quality and Counterfeiting

  • Making the List

    Jane Hutchings, Keith Neroutsos et al.•International Perspectives on…•2010

  • International variations in primary care physician consultation time

    Open Access•Greg Irving, Ana Luísa Neves et al.•BMJ Open•2017

  • An essential medicines list in Ireland

    Open Access•James Larkins, James Larkin et al.•Health Policy•2026

  • Essential medicine shortages, procurement process and supplier response

    Open Access•Vijaya Chebolu-Subramanian, R P Sundarraj•Social Science & Medicine•2021

  • The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing

    Open Access•Xiao Wang, Xuan He et al.•International Journal for Equity…•2023

  • The economic burden of diabetes in India

    Open Access•C A K Yesudian, Charles AK Yesudian et al.•Globalization and Health•2014

  • A systematic review of pooled procurement of medicines and vaccines

    Open Access•Koray Parmaksiz, Elizabeth Pisani et al.•Globalization and Health•2022

  • Combining user fees exemption with training and supervision helps to maintain the quality of drug prescriptions in Burkina Faso

    Open Access•Nicole Atchessi, Valery Ridde et al.•Health Policy and Planning•2013

  • The impact of the National Essential Medicines Policy on prescribing behaviours in primary care facilities in Hubei province of China

    Open Access•Liangle Yang, Chaojie Liu et al.•Health Policy and Planning•2013

  • The effect of essential medicines programme on rational use of medicines in China

    Open Access•Yanhong Gong, Chen Yang et al.•Health Policy and Planning•2016

  • Patient access to health care and medicines across low-income countries

    Open Access•Dru Srivastava, Divya Srivastava et al.•Social Science & Medicine•2015

  • The essential drugs programme in Zimbabwe

    Open Access•Richard Laing, RUTH RUREDZO•Health Policy and Planning•1989

Obras citantes distintas11
Citações por ano0,69
Intervalo de citações2010 - 2026 (17)
Velocidade de citaçãocurrent
Altamente citadoNão
Tipos de citaçãoNeutras: 10
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae